Probenecid, an organic anion transporter 1 and 3 inhibitor, increases plasma and brain exposure of N-acetylcysteine

1. N-acetylcysteine (NAC) is being investigated as an antioxidant for several conditions including traumatic brain injury, but the mechanism by which it crosses membrane barriers is unknown. We sought to understand how the transporter inhibitor, probenecid, affects NAC pharmacokinetics and to evalua...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Xenobiotica
Autores principales: Hagos, Fanuel T., Daood, Monica J., Ocque, Jacob A., Nolin, Thomas D., Bayir, Hulya, Poloyac, Samuel M., Kochanek, Patrick M., Clark, Robert S.B., Empey, Philip E.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2016
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5572076/
https://ncbi.nlm.nih.gov/pubmed/27278858
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/00498254.2016.1187777
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares